A. Berchuck

1.9k total citations
42 papers, 1.4k citations indexed

About

A. Berchuck is a scholar working on Reproductive Medicine, Molecular Biology and Oncology. According to data from OpenAlex, A. Berchuck has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Reproductive Medicine, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in A. Berchuck's work include Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Endometriosis Research and Treatment (4 papers). A. Berchuck is often cited by papers focused on Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Endometriosis Research and Treatment (4 papers). A. Berchuck collaborates with scholars based in United States, United Kingdom and Brazil. A. Berchuck's co-authors include Robert C. Bast, Daniel L. Clarke‐Pearson, John T. Soper, Regina S. Whitaker, James Lancaster, Brian Calingaert, L. Havrilesky, George J. Olt, Noah D. Kauff and David G. Mutch and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

A. Berchuck

42 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Berchuck United States 21 673 417 375 337 226 42 1.4k
Maria L. Carcangiu United States 21 378 0.6× 329 0.8× 258 0.7× 413 1.2× 210 0.9× 32 1.4k
Michele De Nictolis Italy 19 481 0.7× 333 0.8× 348 0.9× 326 1.0× 145 0.6× 52 1.3k
Christine Chow Canada 18 618 0.9× 648 1.6× 378 1.0× 384 1.1× 290 1.3× 41 1.5k
Atsushi Hongo Japan 26 422 0.6× 829 2.0× 539 1.4× 482 1.4× 91 0.4× 58 2.0k
Eliane Mery-Lamarche France 23 431 0.6× 333 0.8× 587 1.6× 579 1.7× 214 0.9× 64 1.7k
Yoshihiro Ohishi Japan 24 594 0.9× 529 1.3× 459 1.2× 491 1.5× 158 0.7× 84 1.7k
Renata Tassi Italy 20 503 0.7× 394 0.9× 337 0.9× 341 1.0× 56 0.2× 30 1.3k
Mona Ridderheim Sweden 13 391 0.6× 197 0.5× 143 0.4× 307 0.9× 131 0.6× 26 825
Germana Tognon Italy 18 740 1.1× 264 0.6× 594 1.6× 333 1.0× 88 0.4× 38 1.2k
Bojana Djordjevic Canada 25 672 1.0× 679 1.6× 808 2.2× 314 0.9× 412 1.8× 57 1.9k

Countries citing papers authored by A. Berchuck

Since Specialization
Citations

This map shows the geographic impact of A. Berchuck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Berchuck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Berchuck more than expected).

Fields of papers citing papers by A. Berchuck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Berchuck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Berchuck. The network helps show where A. Berchuck may publish in the future.

Co-authorship network of co-authors of A. Berchuck

This figure shows the co-authorship network connecting the top 25 collaborators of A. Berchuck. A scholar is included among the top collaborators of A. Berchuck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Berchuck. A. Berchuck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alvarez-Secord, A., L. Havrilesky, Victoria Bae‐Jump, et al.. (2007). The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecologic Oncology. 107(2). 285–291. 100 indexed citations
2.
Lancaster, James, Noah D. Kauff, Ilana Cass, et al.. (2007). Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆. Gynecologic Oncology. 107(2). 159–162. 170 indexed citations
3.
Lancaster, Johnathan M., Holly K. Dressman, Jennifer Clarke, et al.. (2006). Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. International Journal of Gynecological Cancer. 16(5). 1733–1745. 60 indexed citations
4.
Jewell, Elizabeth L., Angeles Alvarez Secord, Timothy W. Brotherton, & A. Berchuck. (2006). Use of trastuzumab in the treatment of metastatic endometrial cancer. International Journal of Gynecological Cancer. 16(3). 1370–1373. 20 indexed citations
5.
Havrilesky, L., Janiel M. Cragun, Brian Calingaert, et al.. (2005). Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecologic Oncology. 99(3). 689–695. 81 indexed citations
6.
Shen, Yu, Fengji Xu, Yinhua Yu, et al.. (2001). OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma. Cancer. 92(11). 2837–2844. 87 indexed citations
7.
Peng, Hongqi, Fengji Xu, Kelly K. Hunt, et al.. (2000). ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. International Journal of Cancer. 86(5). 690–694. 50 indexed citations
8.
Carney, M. W. P., G. Larry Maxwell, James Lancaster, et al.. (1998). Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers☆. Journal of the Society for Gynecologic Investigation. 5(5). 281–285. 18 indexed citations
9.
Olt, George J., John T. Soper, Subramanian Ramakrishnan, et al.. (1996). Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer. American Journal of Obstetrics and Gynecology. 174(4). 1316–1319. 9 indexed citations
10.
Liu, Jianzhong, Mark Conaway, G Rodríguez, et al.. (1995). Relationship between race and interval to treatment in endometrial cancer. Obstetrics and Gynecology. 86(4). 486–490. 51 indexed citations
11.
Wiener, Jon R., Jean Hurteau, Billie‐Jo M. Kerns, et al.. (1994). Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. American Journal of Obstetrics and Gynecology. 170(4). 1177–1183. 72 indexed citations
12.
Clarke-Pearson, D., John T. Soper, A. Berchuck, et al.. (1992). Closed retroperitoneal suction drainage following selective lymphadenectomy: Risks and benefits. Gynecologic Oncology. 45(1). 89–89. 1 indexed citations
13.
Olt, George J., et al.. (1992). Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer. Cancer. 70(8). 2137–2142. 6 indexed citations
14.
O'Briant, Kathy, Verda J. Hunter, L. Daly, et al.. (1992). Ha-ras polymorphisms in epithelial ovarian cancer. Gynecologic Oncology. 45(3). 299–302. 4 indexed citations
15.
Jacobs, Ian, M F Kohler, Roger W. Wiseman, et al.. (1992). Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome Inactivation. JNCI Journal of the National Cancer Institute. 84(23). 1793–1798. 129 indexed citations
16.
Soper, John T., A. Berchuck, & Daniel L. Clarke‐Pearson. (1991). Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging. Cancer. 68(4). 725–729. 8 indexed citations
17.
Clarke-Pearson, D., William A. Cliby, John T. Soper, et al.. (1991). Morbidity and mortality of selective lymphadenectomy in early-stage endometrial cancer. Gynecologic Oncology. 40(2). 168–168. 1 indexed citations
18.
Hunter, Verda J., L. Daly, Michael J. Helms, et al.. (1990). The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction. American Journal of Obstetrics and Gynecology. 163(4). 1164–1167. 44 indexed citations
19.
Shpall, Elizabeth J., D. Clarke-Pearson, John T. Soper, et al.. (1990). High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. Gynecologic Oncology. 38(3). 386–391. 40 indexed citations
20.
Olt, George J., A. Berchuck, & Robert C. Bast. (1990). Gynecologic tumor markers. Seminars in Surgical Oncology. 6(6). 305–313. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria L. Carcangiu Breakdown of academic impact, for papers by Michele De Nictolis Breakdown of academic impact, for papers by Christine Chow Breakdown of academic impact, for papers by Atsushi Hongo Breakdown of academic impact, for papers by Eliane Mery-Lamarche Breakdown of academic impact, for papers by Yoshihiro Ohishi Breakdown of academic impact, for papers by Renata Tassi Breakdown of academic impact, for papers by Mona Ridderheim Breakdown of academic impact, for papers by Germana Tognon Breakdown of academic impact, for papers by Bojana Djordjevic
Rankless by CCL
2026